A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Flurandrenolide
Mianserin
Chlorprothixene may increase the anticholinergic activities of Mianserin.
Flurandrenolide
Aclidinium
The risk or severity of adverse effects can be increased when Chlorprothixene is combined with Aclidinium.
Flurandrenolide
Thalidomide
Chlorprothixene may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Flurandrenolide
Tapentadol
Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Chlorprothixene.
Flurandrenolide
Suvorexant
Chlorprothixene may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.
Flurandrenolide
Sodium oxybate
Sodium oxybate may increase the central nervous system depressant (CNS depressant) activities of Chlorprothixene.
Flurandrenolide
Rufinamide
The risk or severity of adverse effects can be increased when Rufinamide is combined with Chlorprothixene.
Flurandrenolide
Rotigotine
Chlorprothixene may increase the sedative activities of Rotigotine.
Flurandrenolide
Perampanel
Perampanel may increase the central nervous system depressant (CNS depressant) activities of Chlorprothixene.
Flurandrenolide
Paraldehyde
Chlorprothixene may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.
Flurandrenolide
Orphenadrine
Chlorprothixene may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.
Flurandrenolide
Methotrimeprazine
Chlorprothixene may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.
Flurandrenolide
Hydrocodone
Chlorprothixene may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.
Oxazepam
Fostamatinib
The risk or severity of hypotension can be increased when Fostamatinib is combined with Levodopa.
Oxazepam
Mirodenafil
The risk or severity of hypotension can be increased when Mirodenafil is combined with Levodopa.
Oxazepam
Doxofylline
The risk or severity of hypotension can be increased when Doxofylline is combined with Levodopa.
Oxazepam
Udenafil
The risk or severity of hypotension can be increased when Udenafil is combined with Levodopa.
Oxazepam
Avanafil
The risk or severity of hypotension can be increased when Avanafil is combined with Levodopa.
Oxazepam
Ibudilast
The risk or severity of hypotension can be increased when Ibudilast is combined with Levodopa.
Oxazepam
Oliceridine
The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Levodopa is combined with Oliceridine.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3